article thumbnail

Moderna sues Pfizer for mRNA Patent Infringement: when optics and profits reveal real issues in modern IP law usage

IPilogue

Moderna and Pfizer battle’s over the inventive process of their respective mRNA COVID-19 vaccines revisit the negative associations of profit, monopolies, and optics in patent litigation. Moderna claimed that they had registered foundational mRNA patents between 2010 and 2016. This exposes some concerns about our patent laws.

article thumbnail

Federal Court Rules that Artificial Intelligence Cannot Be an Inventor under the Patent Act

Delaware Intellectual Property Litigation Blog

In Thaler , the Court confronted, analyzed and answered the question of “can an artificial intelligence machine be an ‘inventor’ under the Patent Act?” After analyzing the plain statutory language of the Patent Act and the Federal Circuit authority, the Court held that the “clear answer is no.” at *17-18.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amici Back Jump Rope Company in Supreme Court Case

IP Watchdog

Eagle Forum Education and Legal Defense Fund and the Fair Inventing Fund filed briefs in support of the jump rope company while DivX filed in support of neither party.

article thumbnail

I was already like this before you got here: prior use as an exception to patent infringement

Garrigues Blog

In addition, a third party’s use of an invention before its registration by another is also relevant to assess patent infringement. The right of prior use is set forth in article 63 of the current Patents Law of 2015, the wording of which is practically identical to that of article 54 of the earlier Patents Law of 1986.

article thumbnail

Preliminary Injunction and Patent License Disputes

Patently-O

Symbiont’s US Patent No. The inventor Mark Holt is also owner of Symbiont. Holt was part of forming two additional companies, BJM and Matrix and Symbiont licensed the technology (including the patent) to those companies. patent laws are subject to exclusive jurisdiction of the Federal Court system.

article thumbnail

How does the USPTO Decide the Discretionary Aspect of Institution?

Patently-O

US Inventor Inc. In February 2021, US Inventor and others collectively sued the USPTO asking the court to order the USPTO to issue rulemaking regarding discretionary considerations at the institution stage of AIA Trials. In other words, the patent laws are integral to the lawsuit. by Dennis Crouch. Hirshfeld , No.

article thumbnail

Announcing IPO white paper on Best Practices for Protecting Inventions Relating to Artificial Intelligence

LexBlog IP

These include: How to get the most out of a disclosure interview with AI inventors. For example, how to work with inventors to prepare a strong AI patent that will hold up during prosecution at the Patent Office and in the courts. Including AI considerations from the European Patent Office (EPO), Korea, Japan, China.